SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-165678
Filing Date
2006-08-08
Accepted
2006-08-08 16:05:53
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 217481
2 FORM OF NOTICE OF GRANT OF STOCK OPTIONS dex1096.htm EX-10.96 8706
3 FORM OF INCENTIVE/NON-QUALIFIED STOCK OPTION AGREEMENT dex1097.htm EX-10.97 37500
4 AMENDMENT NO. 3 TO THE LEASE AGREEMENT dex1098.htm EX-10.98 12257
5 CERTIFICATION BY CEO dex311.htm EX-31.1 9165
6 CERTIFICATION BY CFO dex312.htm EX-31.2 9136
7 CERTIFICATION BY CEO & CFO dex32.htm EX-32 4263
  Complete submission text file 0001193125-06-165678.txt   299897
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 061013096
SIC: 2834 Pharmaceutical Preparations